产科护理共识第6号:围存活期分娩
该共识将围存活期分娩定义为妊娠20 0/7周至25 6/7周的分娩,指出约0.5%的分娩发生在妊娠晚期前,这些极早产导致大多数新生儿死亡和超过40%的婴儿死亡。共识描述了围存活期分娩后的新生儿结局,提供了当前证据和干预建议,并概述了家庭咨询框架以纳入知情患者偏好。
要点
- 围存活期分娩定义为妊娠20 0/7周至25 6/7周的分娩。
- 约0.5%的分娩发生在妊娠晚期前,导致大多数新生儿死亡和超过40%的婴儿死亡。
- 围存活期分娩的结局与多种因素相关,包括不可改变因素、可改变的产前产时因素及产后管理。
核心结论
- 该文件描述了围存活期分娩后的新生儿结局,提供了该情况下干预措施的当前证据和建议,并概述了家庭咨询框架以纳入知情患者偏好,旨在基于个体情况和患者价值观为决策提供支持和指导。
研究设计与样本
- 该文件为产科护理共识,由制定机构与方法未在原文中报告。
主要发现
- 约0.5%的分娩发生在妊娠晚期前,这些极早产导致大多数新生儿死亡和超过40%的婴儿死亡。
- 围存活期分娩定义为妊娠20 0/7周至25 6/7周的分娩。
- 与围存活期分娩短期和长期结局相关的因素包括不可改变因素(如胎儿性别、体重、多胎性)、可改变的产前和产时因素(如分娩地点、计划剖宫产或引产干预、产前皮质类固醇和硫酸镁给药)以及产后管理(如出生后开始或暂缓及继续或撤除重症监护)。
- 产前和产时管理选项因具体情况而异,可能包括用于早产临产的短期宫缩抑制治疗以争取产前类固醇给药时间、抗生素用于胎膜早破后延长潜伏期或产时B族链球菌预防,以及因胎儿安危或胎位异常考虑的分娩包括剖宫产。
- 计划进行母体或新生儿干预的围存活期分娩应尽可能在具备母胎和新生儿护理专长及所需基础设施(包括重症监护病房)的中心进行。
关键数值与推荐
- 原文未报告具体推荐条款。
临床怎么用
- 计划进行母体或新生儿干预的围存活期分娩应尽可能在具备母胎和新生儿护理专长及所需基础设施(包括重症监护病房)的中心进行。
- 产前和产时管理选项因具体情况而异,可能包括短期宫缩抑制治疗、抗生素及分娩包括剖宫产。
- 该文件旨在基于个体情况和患者价值观为决策(包括拒绝和接受干预及治疗)提供支持和指导。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Approximately 0.5% of all births occur before the third trimester of pregnancy, and these very early deliveries result in the majority of neonatal deaths and more than 40% of infant deaths. A recent executive summary of proceedings from a joint workshop defined periviable birth as delivery occurring from 20 0/7 weeks to 25 6/7 weeks of gestation. When delivery is anticipated near the limit of viability, families and health care teams are faced with complex and ethically challenging decisions. Multiple factors have been found to be associated with short-term and long-term outcomes of periviable births in addition to gestational age at birth. These include, but are not limited to, nonmodifiable factors (eg, fetal sex, weight, plurality), potentially modifiable antepartum and intrapartum factors (eg, location of delivery, intent to intervene by cesarean delivery or induction for delivery, administration of antenatal corticosteroids and magnesium sulfate), and postnatal management (eg, starting or withholding and continuing or withdrawing intensive care after birth). Antepartum and intrapartum management options vary depending upon the specific circumstances but may include short-term tocolytic therapy for preterm labor to allow time for administration of antenatal steroids, antibiotics to prolong latency after preterm premature rupture of membranes or for intrapartum group B streptococci prophylaxis, and delivery, including cesarean delivery, for concern regarding fetal well-being or fetal malpresentation. Whenever possible, periviable births for which maternal or neonatal intervention is planned should occur in centers that offer expertise in maternal and neonatal care and the needed infrastructure, including intensive care units, to support such services. This document describes newborn outcomes after periviable birth, provides current evidence and recommendations regarding interventions in this setting, and provides an outline for family counseling with the goal of incorporating informed patient preferences. Its intent is to provide support and guidance regarding decisions, including declining and accepting interventions and therapies, based on individual circumstances and patient values.
引用
- Obstetric Care consensus No. 6: Periviable Birth. Obstet Gynecol. 2017. PMID: 28937572. doi:10.1097/AOG.0000000000002352
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。